Profil

Blankert Bertrand

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service d'Analyse pharmaceutique

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Analyse pharmaceutique

ORCID
0000-0002-6667-7677
Main Referenced Co-authors
Hambye, Stéphanie  (78)
Mespouille, Laetitia  (48)
DUEZ, Pierre  (41)
Kauffmann, Jean-Michel (40)
DUBOIS, Philippe  (36)
Main Referenced Keywords
Pharmaceutical analysis (16); Solid-phase extraction (15); Preeclampsia (14); Marinobufagenin (13); Screening (12);
Main Referenced Unit & Research Centers
CIRMAP - Centre d'Innovation et de Recherche en Matériaux Polymères (27)
CISMA - Centre Interdisciplinaire de Spectrométrie de Masse (22)
UMHAP - Centre de Recherche UMONS-Ambroise Paré (22)
CMMI - Centre de Recherche en Microscopie et Imagerie Médicale (1)
CREMH - Mind & Health (1)
Main Referenced Disciplines
Pharmacy, pharmacology & toxicology (207)
Chemistry (184)
Endocrinology, metabolism & nutrition (53)
Chemical engineering (44)
General & internal medicine (19)

Publications (total 243)

The most downloaded
40 downloads
Baroni, A., Vlaminck, L., Mespouille, L., Du Prez, F., Delbosc, N., & Blankert, B. (01 January 2019). TAD click chemistry on aliphatic polycarbonates : a first step toward tailor-made materials. Macromolecular Rapid Communications, 40 (1800743), 1-5. https://hdl.handle.net/20.500.12907/29225

The most cited

106 citations (Scopus®)

Nachtergael, A., Coulembier, O., Dubois, P., Helvenstein, M., Duez, P., Blankert, B., & Mespouille, L. (01 January 2015). Organocatalysis paradigm revisited : are metal-free catalysts really harmless ? Biomacromolecules, 16, 507-514. doi:10.1021/bm5015443 https://hdl.handle.net/20.500.12907/30800

Book chapters or contributions to a collective book as author or co-author

Blankert, B., & Kauffmann, J.-M. (2010). Electroanalytical methods as tools for predictive drug metabolism studies. In Reviews in Pharmaceutical & Biomedical Analysis (pp. 76-83).

Articles accepted in reviewed journal

Soumoy, L., Genbauffe, A., Mouchart, L., Sperone, A., Trelcat, A., Mukeba-Harchies, L., Wells, M., Blankert, B., Najem, A., Ghanem, G., Saussez, S., & Journe, F. (04 January 2024). ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy. Cancer Cell International, 24 (1), 8. doi:10.1186/s12935-023-03196-y
Peer Reviewed verified by ORBi

Gossuin, Y., Duez, P., Blankert, B., Masson, C., Laurent, S., & Rousseau, C. (07 January 2023). NMR relaxometry to monitor chromium (VI) reduction by hydrogen peroxide, ascorbic acid and aluminum powder. Magnetic Resonance in Chemistry, 61, 284-295. doi:10.1002/mrc.5332
Peer Reviewed verified by ORBi

Wells, M., Hambye, S., & Blankert, B. (2023). Preliminary insight into the potential antiplasmodial activity and cytotoxicity of Bufo bufo and Incilius alvarius poison. Toxicon, 227. doi:10.1016/j.toxicon.2023.107092
Peer Reviewed verified by ORBi

Wells, M., Fossepre, M., Hambye, S., Surin, M., & Blankert, B. (December 2022). Uncovering the antimalarial potential of toad venoms through a bioassay-guided fractionation process. International Journal for Parasitology: Drugs and Drug Resistance, 20, 97 - 107. doi:10.1016/j.ijpddr.2022.10.001
Peer Reviewed verified by ORBi

Loyez, M., Wells, M., Hambye, S., Hubinon, F., Blankert, B., Wattiez, R., & Caucheteur, C. (28 July 2021). PfHRP2 detection using plasmonic optrodes: performance analysis. Malaria Journal, 20 (332).
Peer reviewed

Traore, O., Ouedraogo, A., Compaoré, M., Nikiema, K., Zombre, A., Kiendrebeogo, M., Blankert, B., & Duez, P. (16 November 2020). Social perceptions of malaria and diagnostic-driven malaria treatment in Burkina Faso. Heliyon, 6, 05553. doi:10.1016/j.heliyon.2020.e05553
Peer reviewed

Soumoy, L., Wells, M., Ahmad, N., Krayem, M., Ghanem, G., Hambye, S., Saussez, S., Blankert, B., & Journe, F. (2020). 'Toad Venom Antiproliferative Activities on Metastatic Melanoma: Bio-Guided Fractionation and Screening of the Compounds of Two Different Venoms'. Biology, (9), 218-234.
Peer reviewed

Traore, O., Campaore, M., Okusa, P., Hubinon, F., Duez, P., Blankert, B., & Kiendrebeogo, M. (16 May 2020). Development and validation of an original magneto-chromatography device for the whole blood determination of hemozoin, the paramagnetic malaria pigment. Microchemical Journal, 157.
Peer Reviewed verified by ORBi

Baroni, A., Neaga, I., Delbosc, N., Wells, M., Verdy, L., Ansseau, E., Vanden Eynde, J.-J., Belayew, A., Bodoki, E., Oprean, R., Hambye, S., & Blankert, B. (25 September 2019). Bioactive Aliphatic Polycarbonates Carrying Guanidinium Functions: An Innovative Approach for Myotonic Dystrophy Type 1 Therapy. ACS Omega, 4 (19), 18126 - 18135. doi:10.1021/acsomega.9b02034
Peer reviewed

Lenaerts, C., Wells, M., Hambye, S., & Blankert, B. (17 January 2019). Marinobufagenin extraction from Rhinella marina toad glands: alternative approaches for a systematized strategy. Journal of Separation Science, 42 (7), 1384 - 1392. doi:10.1002/jssc.201800879
Peer Reviewed verified by ORBi

Baroni, A., Vlaminck, L., Mespouille, L., Du Prez, F., Delbosc, N., & Blankert, B. (01 January 2019). TAD click chemistry on aliphatic polycarbonates : a first step toward tailor-made materials. Macromolecular Rapid Communications, 40 (1800743), 1-5.
Peer Reviewed verified by ORBi

Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (17 May 2018). Revealing of endogenous Marinobufagin by an ultra-specific and sensitive UHPLC-MS/MS assay in pregnant women. Talanta, 187, 193-199.
Peer Reviewed verified by ORBi

Neaga, I.-O., Hambye, S., Bodoki, E., Palmieri, C., Ansseau, E., Belayew, A., Oprean, R., & Blankert, B. (11 May 2018). Affinity capillary electrophoresis for identification of active drug candidates in myotonic dystrophy type 1. Analytical and Bioanalytical Chemistry, 410, 4495-4507.
Peer Reviewed verified by ORBi

Helvenstein, M., Hambye, S., & Blankert, B. (04 April 2017). Hepatocyte-based flow analytical bioreactor for online xenobiotics metabolism bioprediction. Nanobiomedicine, 4, 1-11.
Peer Reviewed verified by ORBi

Pardo, A., Josse, T., Mespouille, L., Blankert, B., Dubois, P., & Duez, P. (26 January 2017). Synthesis of Quercetin-imprinted Polymer Spherical Particles with Improved Ability to Capture Quercetin Analogues. Phytochemical Analysis, 28 (4), 289-296. doi:10.1002/pca.2674
Peer Reviewed verified by ORBi

Neaga, I.-O., Bodoki, E., Hambye, S., Blankert, B., & Oprean, R. (28 October 2016). Study of nucleic acid-ligand interactions by capillary electrophoretic techniques: A review. Talanta, 148, 247-256.
Peer Reviewed verified by ORBi

Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (15 August 2016). Early prediction of preeclampsia risk assessment: analytical determination for marinobufagenin in pregnant women. Journal of Maternal-Fetal and Neonatal Medicine, 29, 18.
Peer Reviewed verified by ORBi

Helvenstein, M., Stanicki, D., Laurent, S., & Blankert, B. (2015). Interaction between iron oxide nanoparticles and HepaRG cells: a preliminary In vitro evaluation. Journal of Nanomaterials. doi:10.1155/2015/463841
Peer Reviewed verified by ORBi

Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (09 July 2015). Marinobufagenin as a promising preeclampsia risk assessment marker: purification from toad venom and LC-MS identification in human plasma. Pregnancy Hypertension, 5 (3), 213-214.
Peer reviewed

Fouad, M., Helvenstein, M., & Blankert, B. (2015). Ultra High Performance Liquid Chromatography Method for the Determination of Two Recently FDA Approved TKIs in Human Plasma Using Diode Array Detection. Journal of Analytical Methods in Chemistry. doi:10.1155/2015/215128
Peer Reviewed verified by ORBi

Berkers, J. H. M., C., V., O., G., B., B., Conotte, R., Blankert, B., S., J., H., V. P., & E., L. (01 April 2015). 778 MIR-141 expression in clear cell renal cell carcinoma is linked with augmented susceptibility to sunitinib therapy in vivo. European Urology Supplements, 14 (2), 778-e778.
Peer Reviewed verified by ORBi

Nachtergael, A., Coulembier, O., Dubois, P., Helvenstein, M., Duez, P., Blankert, B., & Mespouille, L. (01 January 2015). Organocatalysis paradigm revisited : are metal-free catalysts really harmless ? Biomacromolecules, 16, 507-514. doi:10.1021/bm5015443
Peer Reviewed verified by ORBi

Pardo, A., Mespouille, L., Blankert, B., Trouillas, P., Surin, M., Dubois, P., & Duez, P. (27 August 2014). Quercetin-imprinted chromatographic sorbents revisited : optimization of synthesis and rebinding protocols for application to natural resources. Journal of Chromatography. A, 1364, 128-139.
Peer Reviewed verified by ORBi

Helvenstein, M., Hambye, S., & Blankert, B. (07 July 2014). Determination of three tyrosine kinase inhibitors and one active metabolite by an identical and validated ultra-performance liquid chromatography-DAD method in human plasma. Current Pharmaceutical Analysis, 10, 161-168.
Peer Reviewed verified by ORBi

Pardo, A., Mespouille, L., Blankert, B., Dubois, P., & Duez, P. (24 February 2014). Molecularly imprinted polymers: compromise between flexibility and rigidity for improving capture of template analogues. Chemistry, 20 (12), 3500-3509.
Peer Reviewed verified by ORBi

Hambye, S., Helvenstein, M., Verdy, L., Kahvecioglu, Z. C., Conotte, R., Vanden Eynde, J.-J., Colet, J.-M., & Blankert, B. (10 February 2014). Ultra High Performance Liquid Chromatography method for the determination of Pentamidine and analog in rat biological fluids. Journal of Pharmaceutical and Biomedical Analysis, 95, 54-60.
Peer Reviewed verified by ORBi

Lenaerts, C., Larcy, C., & Blankert, B. (01 June 2013). Analytical aspects of marinobufagenin and its applications in the diagnosis of preeclampsia. Pregnancy Hypertension, 3, 99.
Peer reviewed

Lenaerts, C., Demeyer, M., Gerbaux, P., & Blankert, B. (01 January 2013). Analytical aspects of marinobufagenin. Clinica Chimica Acta, 421, 193-201.
Peer Reviewed verified by ORBi

Pardo, A., Mespouille, L., Dubois, P., Duez, P., & Blankert, B. (13 April 2012). Targeted extraction of active compounds from natural products by molecularly imprinted polymers. Central European Journal of Chemistry, 10 ((3)), 751-765.
Peer Reviewed verified by ORBi

Hambye, S., Stanicki, D., Colet, J.-M., Aliouat, E.-M., Vanden Eynde, J.-J., & Blankert, B. (26 October 2010). Three optimized and validated (using accuracy profiles) LC methods for the determination of pentamidine and new analogs in rat plasma. Talanta, 83, 832-839.
Peer Reviewed verified by ORBi

Yu, D., Van Antwerpen, P., Patris, S., Blankert, B., & Kauffmann, J.-M. (01 July 2010). Enzyme Immobilized Magnetic Nanoparticles for in-line Capillary Electrophoresis and Drug Biotransformation Studies: Application to Paracetamol. Combinatorial Chemistry and High Throughput Screening, 13 (6), 455-460.
Peer Reviewed verified by ORBi

Yu, D., Van Antwerpen, P., Patris, S., Blankert, B., & Kauffmann, J.-M. (01 June 2010). Enzyme Immobilized Magnetic Nanoparticles for in-line Capillary Electrophoresis and Drug Biotransformation Studies: Application to Paracetamol. Combinatorial Chemistry and High Throughput Screening, 13, 455-460.
Peer Reviewed verified by ORBi

Yu, D., Blankert, B., & Kauffmann, J.-M. (07 July 2007). Development of amperometric horseradish peroxidase based biosensors for clozapine and for the screening of thiol compounds. Biosensors and Bioelectronics, 22, 2707-2711.
Peer Reviewed verified by ORBi

Yu, D., Dominguez, O., Blankert, B., Sima, V., Sandulescu, R., Arcos, J., & Kauffmann, J.-M. (07 July 2006). peroxidase-based biosensor supported by nanoporous magnetic silica microparticles for acetaminophen biotransformation and inhibition studies. Electroanalysis, 18, 1637-1642.
Peer Reviewed verified by ORBi

Kimbeni, T., Blankert, B., Kambu, O., Amighi, K., Nsangu, J., & Kauffmann, J.-M. (07 July 2006). Amodiaquine polymeric membrane electrode. Journal of Pharmaceutical and Biomedical Analysis, 41, 70-76.
Peer Reviewed verified by ORBi

Yu, D., Blankert, B., Bodoki, E., Bolo, S., Viré, J.-C., Sandulescu, R., Nomura, A., & Kauffmann, J.-M. (07 July 2006). Amperometric biosensor based on horseradish peroxidase immobilised magnetic microparticles. Sensors and Actuators. B, Chemical, 113, 749-754.
Peer Reviewed verified by ORBi

Elyacoubi, A., Zayed, S. I. M., Blankert, B., & Kauffmann, J.-M. (07 July 2006). Development of an amperometric enzymatic biosensor based on gold modified magnetic nanoporous microparticles. Electroanalysis, 18, 345-350.
Peer Reviewed verified by ORBi

Yu, D., Blankert, B., Viré, J.-C., & Kauffmann, J.-M. (07 July 2005). Biosensors in Drug Discovery and Drug Analysis. Analytical Letters, 38, 1687-1701.
Peer Reviewed verified by ORBi

Suze, V. L., Blankert, B., Kauffmann, J.-M., & Karst, U. (07 July 2005). Prediction of clozapine metabolism by on-line electrochemistry/liquid chromatography/mass spectrometry. Analytical and Bioanalytical Chemistry, 382, 742-750.
Peer Reviewed verified by ORBi

Blankert, B., Hayen, H., Suze, V. L., Karst, U., Bodoki, E., Lotrean, S., Sandulescu, R., Mora Diez, N., Dominguez, O., Arcos, J., & Kauffmann, J.-M. (07 July 2005). Electrochemical, chemical and enzymatic oxidations of phenothiazines. Electroanalysis, 17, 1501-1510.
Peer Reviewed verified by ORBi

Blankert, B., Dominguez, O., El Ayyas, W., Arcos, J., & Kauffmann, J.-M. (07 May 2004). Horseradish peroxidase immobilised solid paraffin carbon paste electrode for the amperometric determination of clozapine. Analytical Letters, 37, 917-928.
Peer Reviewed verified by ORBi

Serradilla-Razola, S., Blankert, B., Quarin, G., & Kauffmann, J.-M. (01 May 2003). Phenothiazine drugs as redox mediators in horseradish peroxidase bioelectrocatalysis. Analytical Letters, 36, 1819-1833.
Peer Reviewed verified by ORBi

Articles accepted in conference proceedings

Loyez, M., Wells, M., Hambÿe, S., Hubinon, F., Blankert, B., Wattiez, R., & Caucheteur, C. (17 May 2022). PfHRP2 detection using plasmonic optical fibers: a step towards early malaria diagnosis. Proceedings of SPIE: The International Society for Optical Engineering, 12139.
Peer reviewed

Oral presentations in conferences with scientific selection committee

Leveque, M., Hambye, S., & Blankert, B. (28 May 2023). Quantification of affinity constants between small molecules and RNA probes representative of steinert’s disease by affinity capillary electrophoresis [Paper presentation]. 21st FORUM OF PHARMACEUTICAL SCIENCES.
Peer reviewed

Leveque, M., Hambye, S., & Blankert, B. (13 September 2022). Identification of new therapeutic candidates targeting representative RNA probes of Steinert’s disease by affinity capillary electrophoresis [Paper presentation]. 12th International Symposium on Drug Analysis & 32nd International Symposium on Pharmaceutical and Biomedical Analysis, Mons, Belgium.
Peer reviewed

Wells, M., Hambye, S., & Blankert, B. (12 September 2022). Development of a bioassay-guided fractionation protocol to unveil toad venoms as a new source of potential antimalarial candidates [Paper presentation]. 12th International Symposium of Drug Analysis 32nd International Symposium on Pharmaceutical and Biomedical Analysis, Mons, Belgium.
Peer reviewed

Traore, O., Compaoré, M., Hubinon, F., Okusa, P., Duez, P., Blankert, B., & Kiendrebeogo, M. (26 October 2021). Diagnostic de la malaria: développement d'une méthode innovante de quantification du pigment malarique [Paper presentation]. XIIIème Edition du Forum national de la Recherche Scientifique et des Innovations Technologiques (FRSIT), Ouagadougou, Burkina Faso.
Peer reviewed

Wells, M., Hambye, S., & Blankert, B. (14 September 2021). Identifying new potential antimalarial compound in toad venoms through a bio-guided fractionation process [Paper presentation]. 1st Congress of the European Venom Network EUVEN.
Peer reviewed

Wells, M., Hambye, S., & Blankert, B. (17 September 2020). Discovery strategies for novel antiplasmodial compounds from the venom of Bufo toads [Paper presentation]. Venoms and Toxins, Oxford, United Kingdom.
Peer reviewed

Wells, M., Soumoy, L., Journe, F., Saussez, S., Hambye, S., & Blankert, B. (04 December 2019). Bio-guided fractionation for the isolation of antiplasmodial and cytotoxic compounds from the venom of Bufo toads [Paper presentation]. 26ème RT-SFET, Paris, France.
Peer reviewed

Lenaerts, C., Wells, M., Hambye, S., & Blankert, B. (12 September 2018). Quantification of endogenous marinobufagin by a high-specific and very sensitive UPLC-MS/MS assay in non-patological pregnancy and preeclampsia [Paper presentation]. DA-PBA 2018 : 11th International symposium on Drug Analysis - 29th International Symposium on Pharmaceutical and Biomedical Analysis, Leuven, Belgium.
Peer reviewed

Romoaldo, G., Hambye, S., Tagliatti, V., Colet, J.-M., & Blankert, B. (12 September 2018). Assessing emotional states.: Metabonomic profiling and quantification of a salivary biomarker [Paper presentation]. DA-PBA 2018 : 11th International symposium on Drug Analysis - 29th International Symposium on Pharmaceutical and Biomedical Analysis, Leuven, Belgium.
Peer reviewed

Neaga, I.-O., Hambye, S., Baroni, A., Bodoki, E., Blankert, B., & Oprean, R. (25 June 2018). Screening drug candidates for myotonic dystrophy type 1: nucleic acid probe design and method development [Paper presentation]. 18th CEEPUS Symposium and Summer School on Bioanalysis 2018, 25 - 30 June, Komarno, Slovakia.
Peer reviewed

Baroni, A., Blankert, B., & Mespouille, L. (20 October 2017). TAD click-chemistry onto Aliphatic PolyCarbonates - A promising platform for tailor-made drug delivery [Paper presentation]. GEMO 2017, Gand, Belgium.
Peer reviewed

Traore, O., Okusa, P. N., Compaoré, M., Duez, P., Blankert, B., & Kiendrebeogo, M. (17 October 2017). Développement d'un dispositif micro-fluidique magnétique pour le diagnostic de la malaria : modélisation et validation physico-chimique du procédé [Paper presentation]. 1er Congrès Scientifique International de la SOPHATOX-BURKINA, Ouagadougou, Burkina Faso.
Peer reviewed

Neaga, I.-O., Bodoki, E., Hambye, S., Blankert, B., & Oprean, R. (06 July 2016). Characterization of oligonucleotides-ligand interactions with implications in myotonic dystrophy [Paper presentation]. 16th CEEPUS Symposium and Summer School on Bioanalysis, Warsaw, Unknown/unspecified.
Peer reviewed

Lenaerts, C., Tuytten, R., Bond, L., Delporte, C., Van Antwerpen, P., & Blankert, B. (06 July 2016). A LC-MS assay for identification and quantification of marinobufagenin in human: a novel approach for preeclampsia risk evaluation [Paper presentation]. MASCL, Salzburg, Austria.
Peer reviewed

Lenaerts, C., Tuytten, R., Bond, L., Delporte, C., Van Antwerpen, P., & Blankert, B. (12 May 2016). Early prediction of preeclampsia risk assessment: analytical determination for marinobufagenin in pregnant women [Paper presentation]. Second International Congress on Maternal Hemodynamics, Rome, Italy.
Peer reviewed

Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (24 September 2015). Marinobufagenin as a promising preeclampsia risk assessment marker: purification from toad venom and LC-MS identification in human plasma [Paper presentation]. ISSHP (International Society for the Study of Hypertension in Pregnancy) 2015, Budapest, Hungary.
Peer reviewed

Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (13 July 2015). Marinobufagenin as a potential biomarker for preeclampsia risk assessment: purification from Bufo Marinus toad venom as support for a human plasma LC-MS/MS assay [Paper presentation]. Joint meeting of the GP-TCM Research Association, the TCM Chemistry Specialty Committee and the TCM Pharmaceutical Analysis Specialty Committee of the World Federation of Chinese Medicine Societies, Mons, Belgium.
Peer reviewed

Lenaerts, C., Bond, L., Tuytten, R., & Blankert, B. (17 October 2014). Analysis of marinobufagenin in plasma for preeclampsia risk assessment: a promising early predictive tool [Paper presentation]. 1st International Congress on Maternal Hemodynamics, Hasselt, Belgium.
Peer reviewed

Mespouille, L., Pardo, A., Duez, P., Blankert, B., & Dubois, P. (22 August 2013). Compromise between flexibility and rigidity in molecularly imprinted [Paper presentation]. 10th International Conference on Advanced Polymers via Macromolecular Engineering, Durham, United Kingdom.
Peer reviewed

Hambye, S., Kauffmann, J.-M., & Blankert, B. (06 June 2009). 'On-line electrochemistry/mass spectrometry: tools of high potentiality for predictive drug biotransformation studies.' [Paper presentation]. Pre-satellite meeting PharmSciFair '09 (Young Pharmaceutical Scientists), Nice, France.
Peer reviewed

Kauffmann, J.-M., & Blankert, B. (15 July 2007). Hyphenated electroanalytical methods as 'in vitro' tools for predictive drug metabolisation studies [Paper presentation]. 8th International Symposium on Pharmaceutical Sciences, Ankara, Turkey.
Peer reviewed

Blankert, B., Van leeuwen, S. M., Karst, U., & Kauffmann, J.-M. (15 July 2007). Couplage de Techniques LC/EC/MS : ouitls de haute potentialité pour l'étude prédictive de la biotransformation de composés d'intérêt pharmaceutique [Paper presentation]. Journée d'Electrochimie, Lyon, France.
Peer reviewed

Suze, V. L., Blankert, B., Kauffmann, J.-M., & Karst, U. (15 March 2006). On-line Electrochemistry/Liquid Chromatography/Mass Spectrometry for Prediction of Clozapine metabolism [Paper presentation]. Pittcon, Orlando, United States - Florida.
Peer reviewed

Yu, D., Blankert, B., & Kauffmann, J.-M. (15 March 2006). Nanoporous magnetic silica particles for enzymes immobilized biosensors and microbioreactors [Paper presentation]. Pittcon, Orlando, United States - Florida.
Peer reviewed

Suze, V. L., Blankert, B., Kauffmann, J.-M., & Karst, U. (15 February 2006). Electrochemistry/liquid chromatography/mass spectrometry for prediction of clozapine phase I and II metabolism [Paper presentation]. Ninth International Symposium on Hyphenated Techniques in Chromatography, York, United Kingdom.
Peer reviewed

Posters presentations in conferences with scientific selection committee

Gossuin, Y., Duez, L., Blankert, B., Masson, C., Laurent, S., & Rousseau, C. (July 2023). NMR relaxometry to monitor chromium (VI) reduction by hydrogen peroxide, ascorbic acid and aluminum powder [Poster presentation]. euromar 2023, Glasgow, United Kingdom.
Peer reviewed

Soumoy, L., Wells, M., Najem, A., Krayem, M., Ghanem, G., Hambye, S., Saussez, S., Blankert, B., & Journe, F. (12 September 2022). Uncovering the antiproliferative potential of toad venoms on metastatic melanoma [Poster presentation]. 12th International Symposium of Drug Analysis 32nd International Symposium on Pharmaceutical and Biomedical Analysis, Mons, Belgium.
Peer reviewed

Wells, M., Hambye, S., & Blankert, B. (05 October 2021). Développement d'une stratégie de fractionnement bio-guidé pour l'identification de composés antiplasmodiaux issus de venins de Bufonidae [Poster presentation]. 14ème Congrès Francophone sur les Sciences Séparatives et les Couplages de l'AFSEP, Paris, France.
Peer reviewed

Gossuin, Y., Laurent, S., Masson, C., Duez, P., & Blankert, B. (01 July 2021). Following chromium (IV) reduction by low resolution nuclear magnetic relaxometry [Poster presentation]. euromar.
Peer reviewed

Patents

Duez, P., Roch, A., Blankert, B., Okusa, P. N., & Avaert, R. (06 May 2016). Malaria Detection: Pub. No. WO/2016/066754; International Application No PCT/EP2015/075144; Publication Date 06.05.2016; International Filing Date 29.10.2015.

Contact ORBi UMONS